Search results
H. Michael Shepard (born 1949) is an American cancer researcher who was awarded the 2007 Harvard Medical School Warren Alpert Foundation Prize and the 2019 Lasker Clinical research award, which he shared with Dennis Slamon and Axel Ullrich for their development of Herceptin [1] Education and career.
Mar 15, 2024 · In this World View, H. Michael Shepard describes his personal story behind the discovery of trastuzumab, 25 years since its FDA approval for HER2-overexpressing breast cancers.
Michael Shepard, MD specializes in orthopaedic surgery. He renders the most comprehensive care for knee, elbow and shoulder injuries. Dr. Shepard uses the latest medical technology with the state of art medical facility to provide his patients the best possible outcome.
Nov 30, 2021 · Dr. Shepard, an innovator in the field of biotechnology and pioneer in cancer research, won the 2019 Lasker-DeBakey Clinical Medical Research Award with colleagues Dr. Dennis J. Slamon...
The 2019 Lasker~DeBakey Clinical Medical Research Award honors three scientists—H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich —who invented Herceptin, the first monoclonal antibody that blocks a cancer-causing protein, and developed it into a life-saving therapy for women with breast cancer. The innovation reduces the risk of ...
Jan 31, 2013 · Thunderbird Films co-founders Michael Shepard and Tim Gamble are parting ways. Shepard is leaving the Vancouver-based producer as president to form Mindset Television with a first look financing and distribution deal with Thunderbird in hand.
This scientist from British Columbia has devoted thirty years to studying the technical, scientific and legal aspects of Canada's fishing industry. His knowledge in this field has made him invaluable as a key player in the country's fishing boundary disputes in international arenas.
